Spike glycoprotein E1
Eastern equine encephalitis virus
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Other combination Heteromer Protein × 16 其他Polymer 6 PDB declaration: 16-meric(16) Consistent with protein copy count | Chain A; UniProt 802–1201 Chain B; UniProt 802–1201 Chain C; UniProt 802–1201 Chain D; UniProt 802–1201 Chain E; UniProt 802–1201 Chain F; UniProt 802–1201 | Not recorded | IgG EEEV-373 Heavy chain × 2 IgG EEEV-373 Light chain. × 2 E2 glycoprotein × 6 (A9XR09) beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 | ELECTRON MICROSCOPY cryo-EM buffer:pH 7.4 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 3.80 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 8VSV | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 7N69 Pre-fusion state 2 of EEEV with localized reconstruction Deposited 2021-06-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 12 PDB declaration: dodecameric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
802–1242(441 aa)
Chain D
325–744(420 aa)
Chain E
802–1242(441 aa)
Chain F
325–744(420 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
802–1242(441 aa)
Chain J
325–744(420 aa)
Chain K
802–1242(441 aa)
Chain L
325–744(420 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5.5;pH 5.5
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 3.3 seconds before plunging
|
Resolution 14.10 Å |
| 7N6A Pre-fusion state 1 of EEEV with localized reconstruction Deposited 2021-06-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 12 PDB declaration: dodecameric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
802–1242(441 aa)
Chain D
325–744(420 aa)
Chain E
802–1242(441 aa)
Chain F
325–744(420 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
802–1242(441 aa)
Chain J
325–744(420 aa)
Chain K
802–1242(441 aa)
Chain L
325–744(420 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5.5;pH 5.5
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 3.3 seconds before plunging
|
Resolution 14.30 Å |
| 7V0N Cryo-EM structure of SINV/EEEV in complex with Fab fragment of a moderately/weakly neutralizing human antibody IgG-21 Deposited 2022-05-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 16 PDB declaration: hexadecameric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
Chain a
325–666(342 aa)
Chain b
325–666(342 aa)
Chain c
325–666(342 aa)
Chain d
325–666(342 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.90 Å |
| 7V0O Cryo-EM structure of SINV/EEEV in complex with Fab fragment of a moderately/weakly neutralizing human antibody IgG-94 Deposited 2022-05-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 16 PDB declaration: hexadecameric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
Chain a
325–666(342 aa)
Chain b
325–666(342 aa)
Chain c
325–666(342 aa)
Chain d
325–666(342 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.60 Å |
| 7V0P Cryo-EM structure of SINV/EEEV in complex with Fab fragment of a potently neutralizing human antibody IgG-106 Deposited 2022-05-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 16 PDB declaration: hexadecameric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
Chain a
325–666(342 aa)
Chain b
325–666(342 aa)
Chain c
325–666(342 aa)
Chain d
325–666(342 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.20 Å |
| 8XI4 Structure of Eastern Equine Encephalitis VLP in complex with the receptor VLDLR LA1-2 Deposited 2023-12-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 16 PDB declaration: 16-meric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
1–261(261 aa)
Chain D
802–1242(441 aa)
Chain E
325–744(420 aa)
Chain F
1–261(261 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
1–261(261 aa)
Chain J
802–1242(441 aa)
Chain K
325–744(420 aa)
Chain L
1–261(261 aa)
|
Mutation:K67N Mutation:K67N Mutation:K67N Mutation:K67N | CA CALCIUM ION × 8 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 8XI5 Structure of Eastern Equine Encephalitis VLP in complex with the receptor VLDLR LA3-5 Deposited 2023-12-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 20 PDB declaration: 20-meric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
1–261(261 aa)
Chain D
802–1242(441 aa)
Chain E
325–744(420 aa)
Chain F
1–261(261 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
1–261(261 aa)
Chain J
802–1242(441 aa)
Chain K
325–744(420 aa)
Chain L
1–261(261 aa)
|
Mutation:K67N Mutation:K67N Mutation:K67N Mutation:K67N | CA CALCIUM ION × 8 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å |
| 8YS2 Overall structure of Eastern Equine Encephalitis virus VLP in complex with the receptor VLDLR LA1-2 Deposited 2024-03-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 960 PDB declaration: 960-meric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
1–261(261 aa)
Chain D
802–1242(441 aa)
Chain E
325–744(420 aa)
Chain F
1–261(261 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
1–261(261 aa)
Chain J
802–1242(441 aa)
Chain K
325–744(420 aa)
Chain L
1–261(261 aa)
|
Mutation:K67N Mutation:K67N Mutation:K67N Mutation:K67N | CA CALCIUM ION × 480 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.20 Å |
| 8YS4 Overall structure of Eastern Equine Encephalitis virus VLP in complex with the receptor VLDLR LA3-5 Deposited 2024-03-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 1200 PDB declaration: 1200-meric |
Chain A
802–1242(441 aa)
Chain B
325–744(420 aa)
Chain C
1–261(261 aa)
Chain D
802–1242(441 aa)
Chain E
325–744(420 aa)
Chain F
1–261(261 aa)
Chain G
802–1242(441 aa)
Chain H
325–744(420 aa)
Chain I
1–261(261 aa)
Chain J
802–1242(441 aa)
Chain K
325–744(420 aa)
Chain L
1–261(261 aa)
|
Mutation:K67N Mutation:K67N Mutation:K67N Mutation:K67N | CA CALCIUM ION × 480 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å |
| 9AY1 Cryo-EM structure of SINV/EEEV in complex with a potently neutralizing human antibody IgG EEEV-373 Deposited 2024-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 600 PDB declaration: 600-meric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
|
Not recorded | BMA beta-D-mannopyranose × 60 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 240 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
| 9AY1 Cryo-EM structure of SINV/EEEV in complex with a potently neutralizing human antibody IgG EEEV-373 Deposited 2024-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 10 PDB declaration: decameric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
|
Not recorded | BMA beta-D-mannopyranose × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
| 9AY1 Cryo-EM structure of SINV/EEEV in complex with a potently neutralizing human antibody IgG EEEV-373 Deposited 2024-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 3 Other combination Heteromer;Protein × 50 PDB declaration: 50-meric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
|
Not recorded | BMA beta-D-mannopyranose × 5 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
| 9AY1 Cryo-EM structure of SINV/EEEV in complex with a potently neutralizing human antibody IgG EEEV-373 Deposited 2024-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 4 Other combination Heteromer;Protein × 60 PDB declaration: 60-meric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
|
Not recorded | BMA beta-D-mannopyranose × 6 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
| 9AY1 Cryo-EM structure of SINV/EEEV in complex with a potently neutralizing human antibody IgG EEEV-373 Deposited 2024-03-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 5 Other combination Heteromer;Protein × 10 PDB declaration: decameric |
Chain A
802–1201(400 aa)
Chain B
802–1201(400 aa)
Chain C
802–1201(400 aa)
Chain D
802–1201(400 aa)
|
Not recorded | BMA beta-D-mannopyranose × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
10 other PDB entries and 14 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | POLS_EEEVF |
| Isoform | — |
| PDB entities | 3 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–400; UniProt 802–1201 Author chain B; PDBConstruct 1–400; UniProt 802–1201 Author chain C; PDBConstruct 1–400; UniProt 802–1201 Author chain D; PDBConstruct 1–400; UniProt 802–1201 Author chain E; PDBConstruct 1–400; UniProt 802–1201 Author chain F; PDBConstruct 1–400; UniProt 802–1201 |